康言服药提醒
Published by:
Dongguan Kangyi Medical Technology Co
Description
康言服药提醒主要功能是自动提醒按时用药，帮助用户形成按时服药的习惯，降低重复用药、忘记用药等风险，尤其是中老年人和糖尿病等慢性病患者。它将用户的服药情况传送至云端，方便其他家庭成员、签约医护人员了解并作出应对，随着大数据逐渐丰富将为地方医保、医护人员和连锁药店等第三方赋能，提高经济效益和从业人员的工作效率，多方携手实现以健康为中心的国家战略。
Screenshots
康言服药提醒 FAQ
-
Is 康言服药提醒 free?
Yes, 康言服药提醒 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 康言服药提醒 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 康言服药提醒 cost?
康言服药提醒 is free.
-
What is 康言服药提醒 revenue?
To get estimated revenue of 康言服药提醒 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Malaysia yet.
Ratings History
康言服药提醒 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
康言服药提醒 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
安博智能药盒
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
服药管理
深圳市慢性病防治中心督导服药
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
叮咛吃药提醒-按时吃药
服药提醒，健康生活。
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
Xtratop
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
云度医生
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
雾化助手
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
巨烨健康
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
随医记
跟着医生记录日常的重要事件
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
ZayaCare
Smart Medication
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
应用多-用药帮
|
Unlock
|
Unlock
|
0
|
|
2 years ago |
康言服药提醒 Installs
Last 30 days
康言服药提醒 Revenue
Last 30 days康言服药提醒 Revenue and Downloads
Gain valuable insights into 康言服药提醒 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Health Fitness
- Publisher
- Dongguan Kangyi Medical Technology Co
- Languages
- English, Chinese
- Recent release
- 1.0.11 (2 years ago )
- Released on
- Sep 22, 2021 (3 years ago )
- Also available in
- Poland , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , Nepal , New Zealand , Peru , Philippines , Pakistan , Italy , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Slovakia , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel , India
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.